"Scientists Continue To Fine-Tune Gene Therapies" - Arlene Weintraub
Gene editing isn't free of controversy. Some critics worry that the potential to edit out so-called germline mutations – genetic abnormalities in sperm, eggs or embryos – could theoretically result in changed traits being passed to future generations and could be used to delete undesirable but non-life-threatening traits like short stature. Still, the recent successes have inspired other scientists to target some of the most prevalent diseases. A team at the Icahn School of Medicine at Mount Sinai is planning a 2019 trial of a therapy that will introduce a gene into the coronary arteries that produces a calcium-regulating protein essential for improving heart function in patients with chronic heart failure.
- Icahn School of Medicine at Mount Sinai
Mount Sinai and IBM Researchers Uncover Key to Greater Efficacy in Cancer Treatment
Mar 21, 2019 View All Press Releases
Sanofi, Sema4, Mount Sinai Collaborate on Largest Asthma Study of Its Kind
Dec 04, 2018 View All Press Releases